MRCGP AKT Exam Revision – High Yield Topics from the January 2013 AKT Exam

MRCGP AKT Exam – High Yield Topics from the January 2013 AKT Exam

Dr Mahibur Rahman

After each MRCGP AKT examination, the examiners release a report highlighting key information from the last exam. This includes pass marks and rates, and also key topics – both those that were answered well, and those that GP trainees performed poorly on. These topics are frequently 867805_inhalerexamined again in the next few sittings of the AKT exam, so it is worth ensuring that you have a good understanding of them.

As some of you may be starting your revision for the May 2013 MRCGP AKT Exam, we thought it would be helpful to look at the high yield topics from the latest examiners’ report.

Key facts from the January 2013 MRCGP AKT exam:

The top score was 93.5%
The mean score was 70.7%
The lowest score was 33.5%
The pass mark was 66%
The pass rate was 68.7%

Scores by domain:

Clinical medicine – 70.6%
Evidence interpretation – 66.9%
Organisational – 75.2%

High Yield Topics

The examiners’ report from this diet of the MRCGP AKT exam highlighted the following key topics:

  • Adverse effects for common drugs
  • Administration of drugs by non-prescribers
  • Drug dosage calculations
  • Oral contraception and LARC
  • Paediatrics – recognising normal findings
  • Asthma management in children
  • Colorectal cancer – screening and diagnosis
  • Breast cancer – screening, diagnosis and referral
  • Diabetes – diagnosis, management, interpreting diabetic blood results

The MRCGP AKT is a comprehensive examination, so it is important that you cover the entire curriculum. Remember that 80% of the marks are related to applying knowledge relating to clinical medicine in general practice, 10% to evidence interpretation and 10% to the organisational domain.

Emedica Alumni can get a £20 discount off the Emedica MRCGP AKT course by entering this code when booking: alumnimrcgp

Further reading:
Complete January 2013 AKT Summary report

No Comments

    Leave a Reply